Medscape

Molecular Testing in Dermatology: Who and When to Test

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
Labroots

IVDR: where are we now in molecular testing?

IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
ascopubs.org

Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science Evolves

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...
Cure Today

Molecular Testing Improves Accuracy in Kidney Cancer Diagnosis

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
Acsh.org

Is Molecular ‘Pre-testing' to Establish Eligibility Before CT Lung Cancer Screening Safe and Cost-effective?

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...
The American Journal of Managed Care

Comprehensive Molecular Testing in Patients With Ovarian Cancer

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

Cerebral-spinal fluid molecular test improves early and accurate diagnosis of multiple sclerosis

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...
The American Journal of Managed Care

Overcoming Barriers to Molecular Testing in NSCLC Care: Jorge Nieva, MD

Jorge Nieva, MD, highlights the critical role of molecular testing in non–small cell lung cancer (NSCLC) care, while addressing barriers such as limited tissue samples, delayed turnaround times, and ...
360Dx

Diasorin Submits Point-of-Care Molecular Group A Strep Test to FDA

The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.
Cancer Therapy Advisor

NCCN NSCLC Guidelines Update Staging, Emphasize Molecular Testing

The National Comprehensive Cancer Network’s newly updated non-small cell lung cancer guideline adds sevabertinib as a treatment option for some patients with advanced disease, makes datopotamab ...
Medscape

Molecular Stool Testing Could Cut Post-Polypectomy Colonoscopies by 15%-41%

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...